FIELD: therapeutic methods. SUBSTANCE: into remedy are simultaneously included, by addition or conjugation, vector and enhancer of transcytosis, in particular selected from albumin or its fragments, antibody anti-GP 60 or its fragments, peptide fragments GP 60, PD 1 (proteindisulfide-isomerase) and its fragments. EFFECT: enhanced passage of remedies through endothelium, epithelium, and mesothelium. 8 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF HEPARIN-BINDING ANTAGONISTS IN INHIBITING BRADYKININ RELEASING | 2000 |
|
RU2251433C2 |
| ANTIBODY OR FRAGMENT THEREOF, HAVING NEUTRALISING EFFECT ON HIV, BUT NOT ON IL2 | 2005 |
|
RU2393873C2 |
| ANTIBODY OR FRAGMENT THEREOF WITH HIV-NEUTRALISING ACTIVITY | 2005 |
|
RU2380378C2 |
| FUSED DRUG CONSTRUCTS AND CONJUGATES | 2005 |
|
RU2428431C2 |
| POLYPEPTIDE CAPABLE OF OVERCOMING HEMATOENCEPHALIC BARRIER, AND CONJUGATE THEREOF | 2005 |
|
RU2408605C2 |
| APROTININ POLYPEPTIDES FOR TRANSPORT OF COMPOUND THROUGH BLOOD-BRAIN BARRIER | 2010 |
|
RU2611193C2 |
| ANTIBODIES AGAINST MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) | 2003 |
|
RU2303461C9 |
| MICROPARTICLES DRIED BY SPRAYING AS THERAPEUTIC CARRIERS | 1995 |
|
RU2147226C1 |
| ANTIBODY AGAINST INTERFERON-α/β-BINDING PROTEIN I (IFNAB-BPI) | 1995 |
|
RU2363705C2 |
| ANTIBODY AGAINST INTERFERON-ALPHA/BETA-CONNECTING PROTEIN II (IFNAB-BPII) | 1995 |
|
RU2362781C2 |
